Rachel Elliott

7.1k total citations · 3 hit papers
163 papers, 4.5k citations indexed

About

Rachel Elliott is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Surgery. According to data from OpenAlex, Rachel Elliott has authored 163 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Economics and Econometrics, 35 papers in Geriatrics and Gerontology and 32 papers in Surgery. Recurrent topics in Rachel Elliott's work include Health Systems, Economic Evaluations, Quality of Life (37 papers), Pharmaceutical Practices and Patient Outcomes (29 papers) and Medication Adherence and Compliance (24 papers). Rachel Elliott is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (37 papers), Pharmaceutical Practices and Patient Outcomes (29 papers) and Medication Adherence and Compliance (24 papers). Rachel Elliott collaborates with scholars based in United Kingdom, United States and Australia. Rachel Elliott's co-authors include Katherine Payne, Nick Barber, Matthew Franklin, Tamara Brown, Anthony Avery, Mark Sculpher, John Gladman, Lucy Bradshaw, Deborah Symmons and Lee Hooper and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Rachel Elliott

151 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Economic analysis of the prevalence and clinical and economic burden of medication error in England

2020 207 citations Rachel Elliott, Elizabeth Camacho et al. profile →
Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes

2022 108 citations Chris Sutton, Rachel Elliott et al. New England Journal of Medicine profile →
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study

2024 38 citations Aziz Sheikh, Rachel Elliott et al. profile →

Peers

Countries citing papers authored by Rachel Elliott

Since Specialization

Citations

This map shows the geographic impact of Rachel Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Elliott more than expected).

Fields of papers citing papers by Rachel Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Elliott. The network helps show where Rachel Elliott may publish in the future.

Co-authorship network of co-authors of Rachel Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Elliott. A scholar is included among the top collaborators of Rachel Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Elliott. Rachel Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Economic Evaluations of Medication Safety Interventions in Primary and Long-Term Care: A Systematic Review 2025 ·PharmacoEconomics ·(unknown), (unknown), (unknown), (unknown), Anthony Avery, Darren M. Ashcroft, Antony Chuter, Rachel Elliott	0
2	Differences Between Online Trial Participants Who Have Used Statutory Mental Health Services and Those Who Have Not: Analysis of Baseline Data From 2 Pragmatic Trials of a Digital Health Intervention 2023 ·Journal of Medical Internet Research ·Stefan Rennick‐Egglestone, Chris Newby, Paul H. Robinson, Caroline Yeo, Fiona Ng, Rachel Elliott, Yasmin Ali, Joy Llewellyn‐Beardsley, (unknown), (unknown), Sean P. Gavan, Pim Cuijpers, Stefan Priebe, Charlotte L Hall, Mike Slade	3
3	Knowledge support for optimising antibiotic prescribing for common infections in general practices: evaluation of the effectiveness of periodic feedback, decision support during consultations and peer comparisons in a cluster randomised trial (BRIT2) – study protocol 2023 ·BMJ Open ·Tjeerd van Staa, Anita Sharma, Victoria Palin, (unknown), (unknown), (unknown), Francine Jury, Natalie Gold, William Welfare, Darren M. Ashcroft, (unknown), Rachel Elliott, Chris Sutton, Christopher J. Armitage, Philip Couch, (unknown), (unknown), Iain Buchan	2
4	Evidence-based Recovery Colleges: developing a typology based on organisational characteristics, fidelity and funding 2023 ·Social Psychiatry and Psychiatric Epidemiology ·Daniel Hayes, Elizabeth Camacho, Amy Ronaldson, (unknown), (unknown), Rachel Elliott, Julie Repper, Simon Bishop, Vicky Stergiopoulos, Lisa Brophy, (unknown), (unknown), (unknown), Gary Winship, Sara Meddings, Ioannis Bakolis, Claire Henderson, Mike Slade	16
5	Scaling-up a pharmacist-led information technology intervention (PINCER) to reduce hazardous prescribing in general practices: Multiple interrupted time series study 2022 ·PLoS Medicine ·Sarah Rodgers, (unknown), Stephen A. Roberts, Thomas Allen, Darren M. Ashcroft, James R. Barrett, Matthew Boyd, Rachel Elliott, Kamlesh Khunti, Aziz Sheikh, (unknown), A Niroshan Siriwardena, Anthony Avery	8
6	Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism? 2022 ·British Journal of Clinical Pharmacology ·(unknown), Sean P. Gavan, Darren M. Ashcroft, Niels Peek, Rachel Elliott	8
7	Impact of receiving recorded mental health recovery narratives on quality of life in people experiencing non-psychosis mental health problems (NEON-O Trial): updated randomised controlled trial protocol 2022 ·Trials ·Stefan Rennick‐Egglestone, Rachel Elliott, Chris Newby, Paul H. Robinson, Mike Slade	7
8	Is spurious penicillin allergy a major public health concern only in high-income countries? 2021 ·BMJ Global Health ·Mamidipudi Thirumala Krishna, Pudupakkam K. Vedanthan, Rajesh Vedanthan, (unknown), Madhan Ramesh, Hoa L. Nguyen, (unknown), Iestyn Williams, Biraj Karmacharya, Seetharaman Hariharan, Kandamaran Krishnamurthy, (unknown), Rachel Elliott, P A Mahesh, John Marriott	11
9	Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial 2021 ·Thorax ·Martin J Wildman, Alicia O’Cathain, Chin Maguire, Madelynne A Arden, (unknown), Judy Bradley, Stephen J. Walters, Pauline Whelan, John Ainsworth, Iain Buchan, Laura Mandefield, Laura Sutton, Paul Tappenden, Rachel Elliott, Zhe Hui Hoo, Sarah J Drabble, Daniel Beever	22
10	Health status of UK care home residents: a cohort study 2013 ·Age and Ageing ·Adam Gordon, Matthew Franklin, Lucy Bradshaw, Pip Logan, Rachel Elliott, John Gladman	268
11	Oral Session 4 – User perspectives 2010 ·International Journal of Pharmacy Practice ·Nde-Eshimuni Salema, Rachel Elliott, Cris Glazebrook, C Morecroft, Linda Mason, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
12	A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery 2008 ·Health Technology Assessment ·Gillian Cranny, Rachel Elliott, Helen Weatherly, Duncan Chambers, Neil Hawkins, Lindsey Myers, Mark Sculpher, Alison Eastwood	38
13	A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management 2008 ·Health Technology Assessment ·J Thornton, Darren M. Ashcroft, Terence W O’Neill, Rachel Elliott, J.E. Adams, Chris Roberts, Madeleine Rooney, Deborah Symmons	18
14	Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model 2006 ·Health Technology Assessment ·Linda Davies, Tamara Brown, Shana M Haynes, Katherine Payne, Rachel Elliott, Charles McCollum	166
15	Benefits and Consequences for the Poor and the Disabled 2005 ·New England Journal of Medicine ·Rachel Elliott, Sumit R. Majumdar, Muriel R. Gillick, Stephen B. Soumerai	24
16	Clinical and economic choices in anaesthesia for day surgery 2003 ·Anaesthesia ·Rachel Elliott	3
17	Can Britain and the United States learn anything from each other 2003 ·Pharmaceutical journal/The pharmaceutical journal ·Rachel Elliott, (unknown), (unknown)	1
18	Prove the value of pharmacy 1997 ·Pharmacy Practice ·Rachel Elliott, Katherine Payne, Jonathan Silcock	1
19	Health Economics: Do or be done by 1996 ·Pharmaceutical journal/The pharmaceutical journal ·Rachel Elliott, Katherine Payne, Jonathan Silcock	2
20	Vasovagal response during oral surgery. 1976 ·PubMed ·(unknown), (unknown), (unknown), Rachel Elliott	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact